Detalhe da pesquisa
1.
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Nature
; 620(7976): 1063-1070, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587335
2.
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.
Gynecol Oncol
; 168: 68-75, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401943
3.
Profiling the immune landscape in mucinous ovarian carcinoma.
Gynecol Oncol
; 168: 23-31, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368129
4.
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Mod Pathol
; 34(1): 194-206, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724153
5.
Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei.
BMC Cancer
; 20(1): 369, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357859
6.
Therapeutic options for mucinous ovarian carcinoma.
Gynecol Oncol
; 156(3): 552-560, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31902686
7.
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
Gynecol Oncol
; 158(3): 702-709, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641237
8.
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
Cancer
; 125(12): 1963-1972, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30835824
9.
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
BMC Cancer
; 18(1): 87, 2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357823
10.
Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.
Gynecol Oncol
; 150(2): 239-246, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29807697
11.
Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma.
Histopathology
; 70(2): 309-313, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27442838
12.
Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Gynecol Oncol
; 142(3): 458-64, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27444035
13.
Synthetic lethality between CCNE1 amplification and loss of BRCA1.
Proc Natl Acad Sci U S A
; 110(48): 19489-94, 2013 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24218601
14.
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.
J Pathol
; 229(3): 469-76, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23096461
15.
The challenges of gene expression microarrays for the study of human cancer.
Cancer Cell
; 9(5): 333-9, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16697954
16.
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.
NPJ Precis Oncol
; 8(1): 68, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480868
17.
Profiling the cancer genome.
Annu Rev Genomics Hum Genet
; 11: 133-59, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20590430
18.
Options available--from start to finish--for obtaining data from DNA microarrays II.
Nat Genet
; 32 Suppl: 481-9, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12454642
19.
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Sci Rep
; 13(1): 21884, 2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072854
20.
Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma.
Transl Oncol
; 31: 101638, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805919